Navigation Links
Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
Date:11/7/2012

JERUSALEM, November 7, 2012 /PRNewswire/ --

Oramed Pharmaceuticals Inc. (OTCBB: ORMP; www.oramed.com), a developer of oral delivery systems, announced today that results of a study performed using its oral insulin formulation, ORMD-0801, have been accepted for presentation at the 12th Annual Diabetes Technology Society Meeting.  The abstract, titled "Concomitant oral and subcutaneous insulin therapy toward stabilization of uncontrolled T1DM," will be presented by Oramed's Chief Scientific Officer, Dr. Miriam Kidron, during the poster session being held from 4pm to 6:30pm (EST), on Thursday, November 8th. The meeting will take place at the Bethesda North Marriott Hotel & Conference Center.

Type 1 Diabetes Mellitus (T1DM), formerly known as juvenile diabetes, affects both young and adult populations. T1DM makes up approximately 5-10% of diabetes cases, and approximately $2 billion of the estimated $15 billion global insulin market. In this form of the disease, an autoimmune reaction destroys the body's insulin-producing cells in the pancreas making its patients completely dependent upon insulin from an external source.

T1DM is occasionally associated with instability and unpredictability of glycemic readings, resulting in poor control of blood sugar.  In severe cases, this condition has a disruptive impact on patient quality of life, due to inadequate clinical solutions. The study to be presented at the Diabetes Technology Society Meeting, and conducted in 2010, evaluated the safety and stabilizing potential of concomitant oral and subcutaneous insulin therapy in volunteers diagnosed with unstable T1DM. Concomitant administration of Oramed's oral insulin formulation, ORMD-0801, and subcutaneous insulin proved safe and well tolerated.  In addition, support with ORMD-0801 led to more frequent blood glucose readings within the healthy range (< 70 mg/dL) and to fewer readings within the
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
2. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
3. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
6. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
7. Icahn Issues Statement Regarding Amylin Pharmaceuticals
8. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
11. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  A novel wearable injector slightly ... and painless for patients to self-inject prescription drugs in the ... including cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... grow to $220B by 2018, according to analysts.   Many of ...
(Date:1/14/2014)... HARRISBURG, Pa. , Jan. 14, 2014 Dynamic Healthcare ... ("GMH"), announced today that it acquired Progressive Home Medical Equipment, ... January 7, 2014. The terms of the acquisition were not ... medical equipment ("DME") company providing a wide range of sleep, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... Pharmaceuticals, Inc. (Nasdaq: REGN ) will webcast ... Conference on Wednesday, November 10, 2010.  The presentation is ... Time).  The session may be accessed through the Company,s ... page.  An archived version of the presentation will be ...
... than half of the life sciences start-up companies in ... of funding through the Therapeutic Discovery Project Credit under ... of 2010. Seed ... SonarMed all learned today from the Internal Revenue Service ...
Cached Medicine Technology:Indiana Life Sciences Start Ups Garner More than $1.5 Million in Competitive Federal Funding 2
(Date:4/24/2014)... Ever since it was first identified more than ... to play an integral role in preventing the onset ... either lost or mutated, malignant cells can grow unchecked ... by investigators at Beth Israel Deaconess Medical Center (BIDMC) ... effects and how its loss or alteration can set ...
(Date:4/24/2014)... with the negative and stressful outcomes for parents who ... a life-limiting illness, says a recent study led by ... the challenges are numerous and life-changing and stress levels ... the Waterloo-led research reported positive outcomes as well, a ... the most recent issue of the American Journal ...
(Date:4/24/2014)... for BrainHealth will bring together national experts to ... at its inaugural Brain Health Summit, titled "The ... will include Dr. Sandra Bond Chapman, founder and ... Senator Chuck Grassley (R-IA), U.S. Representative Chaka Fattah ... Policy and Early Learning, U.S. Department of Education. ...
(Date:4/24/2014)... to the epidemic of prescription opioid overdose deaths was ... Medicine by leaders of agencies in the U.S. ... calls upon health care providers to expand their use ... deaths, and describes a number of misperceptions that have ... also discusses how medications can be used in combination ...
(Date:4/24/2014)... Dartmouth has been awarded one of 30 grants from ... Lead Academic Participating Site in its new National ... a select groups of investigators charged with distributing resources ... The NCTN grant system reflects recommendations from a ... to achieve four goals:, Faster design, launch, ...
Breaking Medicine News(10 mins):Health News:Surprising new insights into the PTEN tumor suppressor gene 2Health News:Surprising new insights into the PTEN tumor suppressor gene 3Health News:Parents of severely ill children see benefits as caregivers, says study 2Health News:Inaugural Brain Health Summit focuses on brain resilience and regeneration 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 3Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 4Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3
... Campaign Explores Decisions Made by the Tobacco Industry, Impact on Americans ... /PRNewswire/ -- Each and every ... heart disease and cancers, to emphysema and strokes. The latest advertising ... the kinds of decisions tobacco industry executives undertake -- decisions that ...
... will present at the Goldman Sachs 30th Annual Global Healthcare ... and chief executive officer, and Thomas C. Freyman, executive vice ... on the company at 9:20 a.m. Central time. , ... accessible through Abbott,s Investor Relations Web site at ...
... ORLANDO - A vaccine for one of the most lethal ... survival for patients when combined with the immunotherapy drug, Interleukin-2, ... Anderson Cancer Center. The findings, presented today at ... vaccine study in the disease - and one of ...
... must take place if a wound is to heal or ... through a branching and further growth of a vessel against ... at Uppsala University and its University Hospital has shown that ... The findings, published today in the journal Nature Medicine ...
... of Abdominal Aortic Aneurysms , , IRVINE, ... ELGX ) today announced the full commercial launch of ... of large neck abdominal aortic aneurysms (AAA). The IntuiTrak ... delivery systems that enhance vascular accessibility and maneuverability while ...
... K9 Clone DOG-1 Immunohistochemical and H. pylori Monoclonal Antibody ... PLUS Diagnostics , a leading U.S. ... services, announced today that it is the first national ... diagnoses the rare gastrointestinal stromal tumor ("GIST"). Known ...
Cached Medicine News:Health News:Video: truth(R) Asks: 'Do You Have What it Takes?' 2Health News:Video: truth(R) Asks: 'Do You Have What it Takes?' 3Health News:Video: truth(R) Asks: 'Do You Have What it Takes?' 4Health News:Vaccine shows therapeutic promise against advanced melanoma 2Health News:Vaccine shows therapeutic promise against advanced melanoma 3Health News:Model for new generation of blood vessels challenged 2Health News:Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System 2Health News:Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System 3Health News:PLUS Diagnostics First National Laboratory to Offer Highly Specialized Gastrointestinal Tests 2
... SAFE-T-FILL Capillary Blood Collection Tubes are 100% ... a wide range of applications, the Capillary ... tube, attached cap and a micro tube.,The ... the blood into the micro tube thereby ...
... Capillary Blood Collection Tubes are 100% plastic ... wide range of applications, the Capillary Collection ... attached cap and a micro tube.,The capillary ... blood into the micro tube thereby eliminating ...
... Scientifics SAFE-T-FILL Capillary Blood Collection Tubes are ... for a wide range of applications, the ... capillary tube, attached cap and a micro ... draw the blood into the micro tube ...
... Scientifics SAFE-T-FILL Capillary Blood Collection Tubes are ... for a wide range of applications, the ... capillary tube, attached cap and a micro ... draw the blood into the micro tube ...
Medicine Products: